Exsitec – Acquisition of M-flow Finland

Exsitec – Acquisition of M-flow Finland

Employment law risks and obligations need to be taken care of in M&A projects.

Our employment lawyers are actively involved in M&A projects. Together with our firm’s experts in other fields of law we will ensure that your business operations continue as smoothly as possible both during and after your M&A project.

Our employment law services in M&A projects include:

  • Due diligence reviews of employment law issues
  • Obligations under the Co-operation Act
  • Social insurance issues
  • Personnel effects arising from M&A projects and implementation thereof
  • Employment and director agreements

Our clients in M&A projects are always companies.

Latest references

DNA – Global brand portfolio management and IP enforcement
We are advising DNA Plc in brand protection and intellectual property enforcement matters globally. Our intellectual property team manages DNA’s global trademark portfolio, including registration, prosecution, opposition and enforcement. We also advise DNA in questions concerning consumer and marketing law, unfair competition, social media, domain names and cybersquatting. DNA Plc is one of Finland’s leading telecommunication companies. DNA offers connections, services and devices for homes and workplaces, contributing to the digitalisation of society. The company has approximately 3.7 million subscriptions in its fixed and mobile communications networks. In 2024, DNA’s total revenue was EUR 1,100 million, and the company employs about 1,600 people around Finland. DNA is part of Telenor Group.
Case published 7.5.2025
WithSecure  –  Sale of cyber security consulting business
We advised WithSecure Corporation in the sale of its cybersecurity consulting business to Neqst. WithSecure is a global cyber security company (listed on NASDAQ OMX Helsinki). Neqst is a Swedish investment firm, focusing on technology companies. The closing of the transaction remains subject to customary conditions and regulatory approvals.
Case published 24.1.2025
Smarter Contracts – Registration of the first non-EU data intermediation service in Finland
We assisted Smarter Contracts Ltd in the process where the Finnish Transport and Communications Agency Traficom confirmed it to be an EU-recognised data intermediation service. Non-EU companies must have a legal representative in some EU country so that they can offer data intermediation services in accordance with the Data Governance Act. Smarter Contracts is based in Great Britain and selected Finland for the task. Smarter Contracts is the first non-EU data intermediation service registered by Traficom. Wayne Lloyd, Founder & CEO of Smarter Contracts, remarked:  The support from the Castrén team was exceptional from start to finish. Pioneering new territory is never without its challenges, and as the first non-EU data intermediation service provider, we faced significant legal uncertainties. Despite these complexities, the Castrén team expertly guided us through each step with remarkable efficiency, providing the certainty we needed. Smarter Contracts leverages its proprietary Pulse Permissions Protocol® to deliver advanced consent and access rights management services. This milestone highlights Castrén & Snellman’s proficiency in navigating intricate regulatory landscapes, whilst recognising the relevance of Smarter Contracts’ innovative approach to secure, compliant data management.
Case published 11.12.2024
Pharmaca Health Intelligence – Acquisition of PODIUM Connect and PODIUM Visits businesses
We assisted Pharmaca Health Intelligence in its acquisition of Mediaattori Ltd’s PODIUM Connect® and PODIUM Visits businesses. Through the acquisition, Pharmaca Health Intelligence strengthens its extensive service offerings in medical information, data-driven management, and education for both healthcare and pharmaceutical companies. Pharmaca Health Intelligence is a pioneer in digital medical information and a reliable partner for wellbeing services counties, the private healthcare sector and pharmacies. The company invests in the development of technology and service solutions related to pharmaceutical information, also on an international scale.
Case published 5.12.2024
All cases

Latest insights

Article published 5.9.2024 – Data & Technology Technology acquisitions can boost companies’ growth – or cause them to fail
Topi Lusenius
Anders Forss
Kim Parviainen

Topi Lusenius, Anders Forss & Kim Parviainen

 Article published 15.5.2025 Latest regulatory developments for renewable energy in Finland
Marius af Schultén
Konsta Peussa

Marius af Schultén & Konsta Peussa

 Article published 9.4.2025 – Dispute Resolution New European Court of Justice ruling C-537/23 sheds light on the interpretation and validity of asymmetric jurisdiction clauses – Implications for European businesses
Robin Ollus
Tuomas Lehtinen

Robin Ollus & Tuomas Lehtinen

 Article published 7.4.2025 – Private Equity & Venture Capital Tax credit for major clean transition investments passed in Parliament – application period until 29 August 2025
Janne Juusela
Mikko Alakare
Samuli Tarkiainen
Marius af Schultén
Jarno Tanhuanpää
Kanerva Sunila
Noora Ahonen

Janne Juusela, Mikko Alakare, Samuli Tarkiainen, Marius af Schultén, Jarno Tanhuanpää, Kanerva Sunila & Noora Ahonen
Insights